Van Lanschot Kempen Wealth Management N.V.
Amsterdam/’s-Hertogenbosch, the Netherlands, 25 February 2021
On 25 February 2021, Van Lanschot Kempen will start the repurchase of up to 400,000 of its own shares (depositary receipts for Class A ordinary shares). At the closing price of 24 February 2021, the programme will cost €8.9 million. It will serve to cover the depositary receipts to be allocated to employees under the existing remuneration policy and share plans.
The share buy-back programme will end on the day before the publication of Van Lanschot Kempen’s 2021 annual figures, or sooner if the maximum number of repurchased shares is reached before then.
Van Lanschot Kempen has tasked ING with the implementation of its share buy-back programme. ING will make its trading decisions independently of Van Lanschot Kempen. Updates on the share buy-back programme will be announced in press releases and on the Van Lanschot Kempen website on a weekly basis on Share buy-back programmes.
Media Relations: +31 20 354 45 85; mediarelations@vanlanschotkempen.com
Investor Relations: +31 20 354 45 90; investorrelations@vanlanschotkempen.com
About Van Lanschot Kempen
Van Lanschot Kempen, a wealth manager operating under the Van Lanschot, Kempen and Evi brand names, is active in Private Banking, Asset Management and Merchant Banking, with the aim of preserving and creating wealth, in a sustainable way, for both its clients and the society of which it is part. Listed at Euronext Amsterdam, Van Lanschot Kempen is the Netherlands’ oldest independent financial services company, with a history dating back to 1737.
For more information, please visit vanlanschotkempen.com
Disclaimer
This is an announcement pursuant to Article 5, paragraph 1, of Regulation (EU) Nr. 596/2014.
This press release does not constitute an offer or solicitation for the sale, purchase or acquisition in any other way or subscription to any financial instrument and is not a recommendation to perform or refrain from performing any action.
This press release is a translation of the Dutch language original and is provided as a courtesy only. In the event of any disparities, the Dutch language version will prevail. No rights can be derived from any translation thereof.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Galapagos NV13.5.2025 07:35:49 CEST | Press release
Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes
Nilfisk Holding A/S13.5.2025 07:30:00 CEST | Press release
Nilfisk reports Q1 2025 results: Financial results in line with expectations – 2025 guidance maintained
Jeito Capital13.5.2025 07:05:00 CEST | Press release
Jeito Capital leads EUR 132 million oversubscribed Series B financing in Azafaros to advance Phase 3 clinical programs of innovative therapies in rare inherited neuro-metabolic disorders
Vivoryon Therapeutics N.V.13.5.2025 07:00:00 CEST | Press release
Vivoryon Therapeutics N.V. to Hold its 2025 Annual General Meeting on June 24, 2025
Kuros Biosciences AG13.5.2025 07:00:00 CEST | Press release
Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom